(Q83229163)
Statements
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study (English)
Craig F Donatucci
Gerald B Brock
Evan R Goldfischer
Peter J Pommerville
Albert Elion-Mboussa
Jay D Kissel